Go Back

Combining data and cancer care expertise to inform the future of cancer care.

Carevive Systems, Inc. founded in 2013, is an oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Our platform enables clinicians to monitor and manage their patients remotely, which improves clinical outcomes and patient quality of life. Use of Carevive in the clinic unlocks critical data on the real-world experience of patients with cancer, to continuously improve patient care today and advance cancer drug development. <br/><br/> <a href="https://www.carevive.com/contact-us/" target="_blank" style="color:#4FAFC9;">Learn more about Carevive here</a><br/>

Carevive

Carevive SMART Data – Refresher

January 1, 2023

Carevive’s digital oncology platform gathers crucial patient experience data, including symptoms, quality of life, social determinants of health, and functional status, directly from patients themselves.

This unique dataset empowers our life science partners to achieve three vital objectives.

Firstly, they can track longitudinal data over time, gaining deeper insights into patient experiences. Secondly, the data can be segmented by drug, biomarker, and patient demographics, enabling targeted analysis. Lastly, these invaluable insights drive enhanced patient adherence and pave the way for future drug development.

Recent Episodes

CensisAI²
View episode

Inside the SPD Revolution: Robby Miller on Embracing CensisAI²

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

resistance
View episode

Inside Oncology Drug Development: Overcoming Resistance with Science

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

organoids
View episode

Growing the Future of Cancer Research: Inside the Promise of Organoids

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert